Similar Papers

Paper Title
Journal
Date
Author
Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
Bruno Fautrel ...
Drugs - real world outcomes | VOL. 11
Bruno Fautrel, et. al.Bruno Fautrel ...
01 Dec 2024
Racial and ethnic differences in COVID-19 outcomes: a call to action.
Philip C Robinson ... Jinoos Yazdany
The Lancet. Rheumatology | VOL. 4
Philip C Robinson, et. al.Philip C Robinson ... Jinoos Yazdany
09 Jun 2022
Long COVID in inflammatory rheumatic diseases-what's in a name?
Leonard H Calabrese
The Lancet. Rheumatology | VOL. 5
Leonard H CalabreseLeonard H Calabrese
01 Jul 2023
AB1521 DIFFERENCES IN DISABILITY OF THE UPPER EXTREMITY AMONG PATIENTS WITH INFLAMMATORY AND NON-INFLAMMATORY RHEUMATIC DISEASES
J A Davila-Jimenez ... D A Galarza-Delgado
Annals of the Rheumatic Diseases | VOL. 83
J A Davila-Jimenez, et. al.J A Davila-Jimenez ... D A Galarza-Delgado
01 Jun 2024
View more papers

More From: Drugs - real world outcomes

Paper Title
Journal
Date
Author
Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA
Manish K Jha ... Kruti Joshi
Drugs - Real World Outcomes | VOL. -
Manish K Jha, et. al.Manish K Jha ... Kruti Joshi
19 Jan 2025
Effectiveness and Safety of Vildagliptin Sustained Release in the Management of Type 2 Diabetes Mellitus: Real-World Evidence in Indian Patients [NOVELTY Study
Rakesh Sahay ... Jaideep Gogtay
Drugs - real world outcomes | VOL. -
Rakesh Sahay, et. al.Rakesh Sahay ... Jaideep Gogtay
16 Jan 2025
Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
Bruno Fautrel ...
Drugs - real world outcomes | VOL. -
Bruno Fautrel, et. al.Bruno Fautrel ...
16 Jan 2025
Patients' Health-Related Quality of Life and Use of Medicinal Cannabis: A Cross-Sectional Survey Study.
Frederik Rosenbæk ... Jens Søndergaard
Drugs - real world outcomes | VOL. -
Frederik Rosenbæk, et. al.Frederik Rosenbæk ... Jens Søndergaard
10 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.